Cargando…
Sirtuin1 attenuates acute liver failure by reducing reactive oxygen species via hypoxia inducible factor 1α
BACKGROUND: The occurrence and development of acute liver failure (ALF) is closely related to a series of inflammatory reactions, such as the production of reactive oxygen species (ROS). Hypoxia inducible factor 1α (HIF-1α) is a key factor that regulates oxygen homeostasis and redox, and the stabili...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099200/ https://www.ncbi.nlm.nih.gov/pubmed/35633910 http://dx.doi.org/10.3748/wjg.v28.i17.1798 |
_version_ | 1784706551350558720 |
---|---|
author | Cao, Pan Chen, Qian Shi, Chun-Xia Wang, Lu-Wen Gong, Zuo-Jiong |
author_facet | Cao, Pan Chen, Qian Shi, Chun-Xia Wang, Lu-Wen Gong, Zuo-Jiong |
author_sort | Cao, Pan |
collection | PubMed |
description | BACKGROUND: The occurrence and development of acute liver failure (ALF) is closely related to a series of inflammatory reactions, such as the production of reactive oxygen species (ROS). Hypoxia inducible factor 1α (HIF-1α) is a key factor that regulates oxygen homeostasis and redox, and the stability of HIF-1α is related to the ROS level regulated by Sirtuin (Sirt) family. The activation of Sirt1 will lead to a powerful antioxidant defense system and therapeutic effects in liver disease. However, little is known about the relationship between HIF-1α and Sirt1 in the process of ALF and the molecular mechanism. AIM: To investigate whether HIF-1α may be a target of Sirt1 deacetylation and what the effects on ALF are. METHODS: Mice were administrated lipopolysaccharide (LPS)/D-gal and exposed to hypoxic conditions as animal model, and resveratrol was used as an activator of Sirt1. The cellular model was established with L02 cells stimulated by LPS. N-acetyl-L-cysteine was used to remove ROS, and the expression of Sirt1 was inhibited by nicotinamide. Western blotting was used to detect Sirt1 and HIF-1α activity and related protein expression. The possible signaling pathways involved were analyzed by immunofluorescent staining, co-immunoprecipitation, dihydroethidium staining, and Western blotting. RESULTS: Compared with mice stimulated with LPS alone, the expression of Sirt1 decreased, the level of HIF-1α acetylation increased in hypoxic mice, and the levels of carbonic anhydrase 9 and Bcl-2-adenovirus E1B interacting protein 3 increased significantly, which was regulated by HIF-1α, indicating an increase of HIF-1α activity. Under hypoxia, the down-regulation of Sirt1 activated and acetylated HIF-1α in L02 cells. The inhibition of Sirt1 significantly aggravated this effect and the massive production of ROS. The regulation of ROS was partly through peroxisome proliferator-activated receptor alpha or AMP-activated protein kinase. Resveratrol, a Sirt1 activator, effectively relieved ALF aggravated by hypoxia, the production of ROS, and cell apoptosis. It also induced the deacetylation of HIF-1α and inhibited the activity of HIF-1α. CONCLUSION: Sirt1 may have a protective effect on ALF by inducing HIF-1α deacetylation to reduce ROS. |
format | Online Article Text |
id | pubmed-9099200 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-90992002022-05-26 Sirtuin1 attenuates acute liver failure by reducing reactive oxygen species via hypoxia inducible factor 1α Cao, Pan Chen, Qian Shi, Chun-Xia Wang, Lu-Wen Gong, Zuo-Jiong World J Gastroenterol Basic Study BACKGROUND: The occurrence and development of acute liver failure (ALF) is closely related to a series of inflammatory reactions, such as the production of reactive oxygen species (ROS). Hypoxia inducible factor 1α (HIF-1α) is a key factor that regulates oxygen homeostasis and redox, and the stability of HIF-1α is related to the ROS level regulated by Sirtuin (Sirt) family. The activation of Sirt1 will lead to a powerful antioxidant defense system and therapeutic effects in liver disease. However, little is known about the relationship between HIF-1α and Sirt1 in the process of ALF and the molecular mechanism. AIM: To investigate whether HIF-1α may be a target of Sirt1 deacetylation and what the effects on ALF are. METHODS: Mice were administrated lipopolysaccharide (LPS)/D-gal and exposed to hypoxic conditions as animal model, and resveratrol was used as an activator of Sirt1. The cellular model was established with L02 cells stimulated by LPS. N-acetyl-L-cysteine was used to remove ROS, and the expression of Sirt1 was inhibited by nicotinamide. Western blotting was used to detect Sirt1 and HIF-1α activity and related protein expression. The possible signaling pathways involved were analyzed by immunofluorescent staining, co-immunoprecipitation, dihydroethidium staining, and Western blotting. RESULTS: Compared with mice stimulated with LPS alone, the expression of Sirt1 decreased, the level of HIF-1α acetylation increased in hypoxic mice, and the levels of carbonic anhydrase 9 and Bcl-2-adenovirus E1B interacting protein 3 increased significantly, which was regulated by HIF-1α, indicating an increase of HIF-1α activity. Under hypoxia, the down-regulation of Sirt1 activated and acetylated HIF-1α in L02 cells. The inhibition of Sirt1 significantly aggravated this effect and the massive production of ROS. The regulation of ROS was partly through peroxisome proliferator-activated receptor alpha or AMP-activated protein kinase. Resveratrol, a Sirt1 activator, effectively relieved ALF aggravated by hypoxia, the production of ROS, and cell apoptosis. It also induced the deacetylation of HIF-1α and inhibited the activity of HIF-1α. CONCLUSION: Sirt1 may have a protective effect on ALF by inducing HIF-1α deacetylation to reduce ROS. Baishideng Publishing Group Inc 2022-05-07 2022-05-07 /pmc/articles/PMC9099200/ /pubmed/35633910 http://dx.doi.org/10.3748/wjg.v28.i17.1798 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
spellingShingle | Basic Study Cao, Pan Chen, Qian Shi, Chun-Xia Wang, Lu-Wen Gong, Zuo-Jiong Sirtuin1 attenuates acute liver failure by reducing reactive oxygen species via hypoxia inducible factor 1α |
title | Sirtuin1 attenuates acute liver failure by reducing reactive oxygen species via hypoxia inducible factor 1α |
title_full | Sirtuin1 attenuates acute liver failure by reducing reactive oxygen species via hypoxia inducible factor 1α |
title_fullStr | Sirtuin1 attenuates acute liver failure by reducing reactive oxygen species via hypoxia inducible factor 1α |
title_full_unstemmed | Sirtuin1 attenuates acute liver failure by reducing reactive oxygen species via hypoxia inducible factor 1α |
title_short | Sirtuin1 attenuates acute liver failure by reducing reactive oxygen species via hypoxia inducible factor 1α |
title_sort | sirtuin1 attenuates acute liver failure by reducing reactive oxygen species via hypoxia inducible factor 1α |
topic | Basic Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099200/ https://www.ncbi.nlm.nih.gov/pubmed/35633910 http://dx.doi.org/10.3748/wjg.v28.i17.1798 |
work_keys_str_mv | AT caopan sirtuin1attenuatesacuteliverfailurebyreducingreactiveoxygenspeciesviahypoxiainduciblefactor1a AT chenqian sirtuin1attenuatesacuteliverfailurebyreducingreactiveoxygenspeciesviahypoxiainduciblefactor1a AT shichunxia sirtuin1attenuatesacuteliverfailurebyreducingreactiveoxygenspeciesviahypoxiainduciblefactor1a AT wangluwen sirtuin1attenuatesacuteliverfailurebyreducingreactiveoxygenspeciesviahypoxiainduciblefactor1a AT gongzuojiong sirtuin1attenuatesacuteliverfailurebyreducingreactiveoxygenspeciesviahypoxiainduciblefactor1a |